Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 987

1.

Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.

Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM.

Am J Cardiol. 2006 Nov 15;98(10):1363-8. Epub 2006 Sep 29.

PMID:
17134630
2.

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.

Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM.

Diabetes Care. 2005 Aug;28(8):1916-21.

PMID:
16043732
3.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

4.

Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS).

Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H.

J Atheroscler Thromb. 2011;18(6):454-63. Epub 2011 Mar 3.

5.

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.

Wang TD, Chen WJ, Chien KL, Seh-Yi Su SS, Hsu HC, Chen MF, Liau CS, Lee YT.

Am J Cardiol. 2001 Oct 1;88(7):737-43.

PMID:
11589839
7.

Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.

St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B.

Am J Cardiol. 2006 Apr 1;97(7):997-1001. Epub 2006 Feb 13.

PMID:
16563904
8.

Plasma triglyceride level and mortality from coronary heart disease.

Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR Jr, O'Grady HK, Davis CE.

N Engl J Med. 1993 Apr 29;328(17):1220-5.

9.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group.

Circulation. 2001 Sep 4;104(10):1108-13.

10.

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW.

J Lipid Res. 1994 May;35(5):779-92.

11.

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH.

Circulation. 1992 Jan;85(1):37-45.

PMID:
1728471
12.

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.

Laakso M, Lehto S, Penttilä I, Pyörälä K.

Circulation. 1993 Oct;88(4 Pt 1):1421-30.

PMID:
8403288
13.

Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study.

Imke C, Rodriguez BL, Grove JS, McNamara JR, Waslien C, Katz AR, Willcox B, Yano K, Curb JD.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1718-22. Epub 2005 Jun 9.

15.

LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.

Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welty TK, Go OT, Howard WJ.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):830-5.

16.
17.

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.

Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL.

Arch Intern Med. 2001 Jun 11;161(11):1413-9.

PMID:
11386890
18.

Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.

Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.

Am J Cardiol. 2007 Nov 15;100(10):1499-501. Epub 2007 Sep 27.

PMID:
17996508
19.

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.

Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.

PMID:
19101227

Supplemental Content

Support Center